PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 158 filers reported holding PRECIGEN INC in Q1 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,363,200 | +23.5% | 960,000 | 0.0% | 0.11% | +7.8% |
| Q2 2023 | $1,104,000 | +8.5% | 960,000 | 0.0% | 0.10% | +21.4% |
| Q1 2023 | $1,017,600 | -30.3% | 960,000 | 0.0% | 0.08% | -41.7% |
| Q4 2022 | $1,459,200 | -28.3% | 960,000 | 0.0% | 0.14% | -12.2% |
| Q3 2022 | $2,035,000 | +58.2% | 960,000 | 0.0% | 0.16% | +107.6% |
| Q2 2022 | $1,286,000 | -36.5% | 960,000 | 0.0% | 0.08% | -28.2% |
| Q1 2022 | $2,026,000 | -81.0% | 960,000 | -66.7% | 0.11% | -6.0% |
| Q4 2021 | $10,686,000 | +123.1% | 2,880,000 | +200.0% | 0.12% | -19.3% |
| Q3 2021 | $4,790,000 | -23.5% | 960,000 | 0.0% | 0.14% | -11.0% |
| Q2 2021 | $6,259,000 | -5.4% | 960,000 | 0.0% | 0.16% | -35.1% |
| Q1 2021 | $6,614,000 | +6.3% | 960,000 | +57.4% | 0.25% | -75.9% |
| Q4 2020 | $6,222,000 | +191.4% | 610,000 | 0.0% | 1.04% | +132.7% |
| Q3 2020 | $2,135,000 | -29.9% | 610,000 | 0.0% | 0.45% | -42.4% |
| Q2 2020 | $3,044,000 | +46.8% | 610,000 | 0.0% | 0.78% | +38.3% |
| Q1 2020 | $2,074,000 | – | 610,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |